Zhong J, Maiseyeu A, Davis SN, et al : DPP4 in cardiometabolic disease : recent insights from the laboratory and clinical trials of DPP4 inhibition. Circ Res 116: 1491-1504, 2015
Birnbaum Y, Castillo AC, Qian J, et al : Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus. Cardiovasc Drugs Ther 26 : 445-456, 2012